Dopamine receptors and genes

Details Dopamine receptors and genes Dopamine receptors and genes

2006-04-04

2006-04-04

Ulm, John D. (Department: 1646)

Chemistry: natural resins or derivatives; peptides or proteins;

Proteins, i.e., more than 100 amino acid residues

C514S002600

Reexamination Certificate

active

07022816

ABSTRACT:
A mammalian D2dopamine receptor gene has been cloned. Thus, DNA sequences encoding all or a part of the dopamine receptor are provided, as well as the corresponding polypeptide sequences and methods for producing the same both synthetically and via expression of a corresponding sequence from a host transformed with a suitable vector carrying the corresponding DNA sequence. The various structural information provided by this invention enables the preparation of labeled or unlabeled immunospecific species, particularly antibodies, as well as nucleic acid probes labeled in conventional fashion. Pharmaceutical compositions and methods of using various products of this invention are also provided.

REFERENCES:
patent: 4599308 (1986-07-01), Hamer et al.
patent: 4650764 (1987-03-01), Temin et al.
patent: 4683195 (1987-07-01), Mullis et al.
patent: 4683202 (1987-07-01), Mullis et al.
patent: 4761371 (1988-08-01), Bell et al.
patent: 4861719 (1989-08-01), Miller
patent: 5422265 (1995-06-01), Civelli
patent: 5569601 (1996-10-01), Civelli
patent: 5880260 (1999-03-01), Civelli
patent: WO91/12339 (1991-08-01), None
patent: WO92/10571 (1992-06-01), None
patent: WO94/03602 (1994-02-01), None
Bunzow et al. Cloning and expression of a rat D2 dopamine receptor cDNA. Dec. 1988. Nature 336:783-788.
Wouters et al. Characterization of cholate-solubilized dopamine receptors from human, dog and rat brain. 1984. Biochemical Pharmacology 33:4049-4044.
Ackenheil, et al., “Antiphsychotishe Wirksarnkeit im Verhaltiszum Plamaspiegal von Clozapin,” Arzneim-Forsch 26, 1156-1158 (1976).
Albert (1984) J. Biol Chem. 259:15350-15363.
Amlaiky and Caron, “Identification of the D2-Dopamine Receptor Binding Subunit in Several Mammalian Tissues and Species by Photoaffinity Labeling,” J. Neurochem. 47, 196-204 (1986).
Abramson, Biochem Pharmacol 37:4289-4297 (1988).
Amlaiky and Caron, “Photoaffinity Labeling of the D2-dopamne Receptor Using a Novel High Affinity Radioiodinated Probe,” J. Biol Chem. 260, 1983-1986 (1985).
Amlaiky, et al., “Identification of the Binding Subunit of the D1-Dopamine Receptorby Photoaffinity Crossliking,” Mol. Pharmacol. 31, 129-134 (1987).
Barnes D.M. Science 241, 415-417 (1988).
Ben-Jonathon (1977) Endocrinology 100:452-458.
Bertling, “Transfection of a DNA/Protein Complex into Nuclei of Mammalian Cells Using Polyoma Capsides and Electroporation,” Bioscience Reports 7, 107112 (1987).
Borgundbvaag V. Life Sci. 37:379-386 (1985).
Botstein, et al., “Construction of a Genetic Linkage Map in Man Using Restriction fragment Length Polymorphisms,” Am. J. Hum. Genet. 32, 314-331 (1980).
Bouvier, et al., “Removal of phosphorylation sites from the b2-adrenergic receptor delays onset of agonist-promoted desensitization,” Nature 333, 370-373 (1988).
Boyson, Neurosci, 6, 3177-3188 (1986).
Bunney B.S. (1973) Nature (New Biol) 245:123-125.
Bunzow, et al., “Cloning and expression of a rat D2 dopamine receptor cDNA,” Nature 336, 783,787 (1988).
Canonico P.L. (1986) J. Endocrinol 110:389-393.
Casey, “Clozapine: neuroleptic-induced EPS and tardive dyskinesia,” Psychophrmacology 99, S47-S53 (1989).
Cole T.E., J. Neural. Trans. Suppl. 18, 139-147 (1983).
Cote, J. Neural Trans Suppl. 18:139-147 (1983).
Cheng, Biochem Pharmacol 22, 3099-3108 (1973).
Cooper, et al., “Catecholamines II: CNS Aspects,” in The Biochemical Basis of Neuropharmacology, 3d ed. 1978 (Oxford University Press, N.Y.), pp. 161-195.
Crease, et al., European J. Pharmacol, 45:(1977) 377-381.
Crease I., Ann. Rev. Neurosci. 6, 43-71 (1983).
Cronin (1983) Am. J. Physiol 244:E499-E504.
Dal Toso, et al, EMBO J. 8, 4025-4034 (1989).
DeCamilli P., (1979) Nature 278:252-254.
Dixon., Nature 321, 75-79 (1986).
Dorflinger, (1983) Endocrinology 113:1541-1500, 1551-1558.
Drouva S. V. Endocrinology 123:2762-2773 (1988).
Young and Davis, “Efficient isolation of genes by using antibody probes,” Proc. Natl. Acad. Sci. USA 80, 1194-1198 (1983).
Dohlman, et al., Biochemistry 26, 2657-2664 (1987).
Dolphin A.C., Trends in Neurosci. 10:53-57 (1987).
Enjalbert A. J., Biol Chem 261:4071-4075 (1986).
Fiers, et al., “Complete nucleotide sequence of SV40 DNA,” Nature 273, 113 (1978).
Gingrich et al., J. Biochemistry 27, 3907-3912 (1988).
Gorman, et al., “High Efficiency DNA-Mediated Transformation of Primate Cells,” Science 221, 551-553 (1983).
Gourdi D., (1979) FEBS Letter 104:165-168.
Grandy, et al., “Cloning of the cDNA and gene for a human D2 dopamine receptor,” Proc. Natl. Acad. Sci. USA 86, 9762-9766 (1989).
Grigoriadis, FEBS Let. 227:220-224 (1988).
Hamblin, M.N. Biochem Pharmacol 33, 877-887.
Hamblin, Life Sci 30:1587-1595 (1982).
Hubbard & Ivatt, “Synthesis and Processing of Asparagine-Lined Oligosaccharides 1.2,” Ann. Rev. Biochem 50, 555-583 (1981).
Hytel J., Eur. J. Pharmacol 91, 153-154 (1983).
Jarvie, et al., “Dopamine D2 Receptor Binding Subunits of Mr. @ 140,000 and 94,000 in Brian: Deglycosylation Yields a Common Unit of Mr. @ 44,000,” Mol. Parmacol. 34, 91-97 (1988).
Jones S.V.P., Proc. Natl. Acad. Sci. USA 85, 4056-4060 (1988).
Journot L., (1987) J. Biol. Chem. 262:15106-15110.
Judd, Endocrinology 123:2341-2350 (1988).
Kane, et al., “Clozapine for the Treatment-Resistant Schizophrenic,” Arch. Gen. Psychiat. 45, 789-796 (1988).
Karose (1983) J. Biol. Chem. 258:4870-4875.
Kebabian and Calne, “Multiple receptors for dopamine,” Nature 277, 93-96 (1979).
Kennedy, et al., “A Hincll RFLP in the human D4 dopamine receptor locus (DRD4),” Nucleic Acids Research 19(20), 5801 (1991).
Kobilka, B.K. Science 238:650-656 (1987).
Kobilka, Nature 329:75-79 (1987).
Koch, Eur. J. Pharmacol. 92:279-283 (1983).
Kozak, “Compliation and analysis of sequences upstream from the translation start site in eukaryotic mRNAs,” Nucleic Acid Res. 12, 857-872 (1984).
Kubo, T. Nature 323:411-416 (1986).
Lacey (1987) J. Physiol 392:397-416.
Law., (1988) Mol. Endocrinology 2:966-972.
Lefkowitz R. J. Biol. Chem. 263:4993-4996 (1988).
Malgaroli, et al., J. Biol. Chem. 262:13920-13927 (1987).
Maso Y, Nature 329:836-838 (1986).
Maziere, et al., Life Sciences., 35:1349-1356 (1984).
Memo M., (1986) J. Neural Trans (Suppl.) 22:19-32.
Mount, “A catalogue of splice junction sequences,” Nucl. Acids. Res. 10, 461-472 (1982).
Mullis, “The Polymerase Chain Reaction: Why It Works,” in Curr. Commun. Mol. Bio., Polymerase Chain Reaction, Erlich, Bibbs & Kazazian, eds., Cold Springs Harbor Press, pp. 237-243.
Neve, Mol. Pharmacol 30, 104-111 (1986).
Ninik, et al., Biochemistry 27, 7594-7599 (1988).
Noonan, et al., “Quantitative Estimation of MDR1 mRNA Levels by Polymerase Chain Reaction,” in Molecular and Cellular Biology of Multidrug Resistance in Tumor Cells, Roninson eds., Plenum Publishing Corporation, 1991, pp. 319-333.
O'Dowd, et al., “Palmitoylation of the Human b2-Adrenergic Receptor,” J. Biol. Chem. 264, 7564-7569 (1989).
Ohara, (1988) Mol. Pharmacol 33:290296.
Onali P., Mol. Pharmacol 28:138-145.
Ozawa S., (1986) Physiol Rev. 66:887-952.
Peterson G.L. Analyt Biochem 83:346-356 (1977).
Quantitative Filter Hybridization: 5.1 Discrimination between related sequences-stringency of hybridization, 1985, in Nucleic Acid Gybridisation: A Practical Approach, Hames & Higgins, eds., IRL Press, pp. 81-82.
Salomon Y.C., Analyt Biochem 58:541-548 (1974).
Sandoz Canada, Inc., Clozaril: Summary of preclinical and clinical data (1990).
Sanger, et al., “DNA sequencing with chain-terminating inhibitors,” Proc. Natl. Acad. Sci. USA 74 (12), 5463-5467 (1977).
Schofield (1983) FEBS Lett 159:79-82.
Schonbrunn (1978) J. Biol. Chem. 253:6473-6483.
Schwartz, et al., J. Neurochemistry, 34 (1980) 772-778.
Seeman, et al., “Human Brain D1 and D2 Dopamine Receptor in Schizophrenia, Alzheimer's, Parkinson's, and Huntington's Diseases,” Neuropshchopharm. 1,

Affiliated with

Also associated with

Rating

Dopamine receptors and genes does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Dopamine receptors and genes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dopamine receptors and genes will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3617425